Discussion about this post

User's avatar
Matt's avatar

So as you know, basic research is often called “Deep Tech” in VC circles. And, yes, it gets a fraction of the investment of software or marketplace or e-bikes. The life of a fund is typically 10 years - so if your potential business can’t get a “liquidity event” in that time, it’s a non-starter.

In Australia, the most prominent Deep Tech VC firm (Main Sequence) was founded by a govt agency (CSIRO) - Mazzucato‘s revenge. A local, well-respected university is starting a pre-seed fund to support their scientist’s inventions because the commercial VCs won’t.

Expand full comment
Connor Clark Lindh's avatar

Well argued and laid out. Building on your “markets / demand for cloning point” I’d argue that the demand shook out more on gene modification rather than full on cloning. It seems there is a market for and active work around gender selection and other modification to reduce the chance of genetic disease or attempts to select for characteristics. In certain parts of society there is considerable demand to “design” your children.

Expand full comment
20 more comments...

No posts